Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer	Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not applicable	2025-04-16		NCT06930807

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangdong Provincial People's Hospital	164
Jiangsu Cancer Institute & Hospital	45
National Institute for Occupational Safety and Health (NIOSH/CDC)	10
Peking University	124
Peking University First Hospital	225
Peking University People's Hospital	269
Second Xiangya Hospital of Central South University	95
Shandong Cancer Hospital and Institute	71
Shanghai Chest Hospital	116
Shanghai Zhongshan Hospital	347
Shenzhen Third People's Hospital	24
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University People's Hospital	Beijing	China	146